n-nitrosoiminodiacetic acid has been researched along with Substance-Related Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botbyl, JD; Campbell, ANC; Luderer, HF; Maricich, YA; Nunes, EV | 1 |
| Boness, CL; DeYoung, CG; Keyser-Marcus, L; Kotov, R; Krueger, RF; Latzman, RD; Moeller, FG; Ramey, T; Watts, AL; Zald, DH | 1 |
| Angelone, L; Gutowski, S; Kostov, Y; Koustova, E | 1 |
| Aklin, WM; Herrmann, ES | 1 |
| Pollock, JD; Satterlee, JS; Volkow, ND | 1 |
| Blackeney, Q; Corbin, M; Crenshaw, K; Huntley, K; Linton, J; Mandell, T; Nolan, L; Subramaniam, GA | 1 |
| Burlew, AK; Hatch-Maillette, M; Lanaway, D; McCuistian, C; Shambley-Ebron, D | 1 |
| Little, AR; Wright, SN | 1 |
| Hatcher, NG; Romanova, EV; Rubakhin, SS; Sweedler, JV | 1 |
| Schuster, C | 1 |
4 review(s) available for n-nitrosoiminodiacetic acid and Substance-Related Disorders
| Article | Year |
|---|---|
New approaches to deep phenotyping in addictions.
Topics: Behavior, Addictive; Humans; Psychopathology; Research Design; Substance-Related Disorders | 2023 |
The NIDA Avenir award in genetics or epigenetics of substance use disorders.
Topics: Awards and Prizes; Epigenesis, Genetic; Humans; Substance-Related Disorders | 2023 |
National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health.
Topics: Adolescent; Adolescent Health; Humans; National Institute on Drug Abuse (U.S.); Substance-Related Disorders; United States | 2023 |
Characterizing intercellular signaling peptides in drug addiction.
Topics: Animals; Humans; Intercellular Signaling Peptides and Proteins; Nitrosamines; Substance-Related Disorders | 2009 |
1 trial(s) available for n-nitrosoiminodiacetic acid and Substance-Related Disorders
| Article | Year |
|---|---|
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study.
Topics: Buprenorphine; Central Nervous System Stimulants; Cocaine; Humans; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders | 2022 |
5 other study(ies) available for n-nitrosoiminodiacetic acid and Substance-Related Disorders
| Article | Year |
|---|---|
NIDA Boosts Research and Development of Medical Devices for Substance use Disorder via the NIH Blueprint MedTech Initiative.
Topics: Drug Overdose; Humans; National Institute on Drug Abuse (U.S.); Research; Substance-Related Disorders; United States | 2023 |
National Institute on Drug Abuse (NIDA) research priorities to support the development of incentive-based treatments for substance use disorders.
Topics: Humans; Motivation; National Institute on Drug Abuse (U.S.); Research; Substance-Related Disorders; United States | 2023 |
One size does not fit all: A NIDA CTN inspired model for community engaged cultural adaptation.
Topics: Humans; Nitrosamines; Substance-Related Disorders | 2020 |
NIDA vision for big data science to understand the biological underpinnings of substance use disorders.
Topics: Data Science; Humans; Nitrosamines; Substance-Related Disorders | 2021 |
Initiatives at the National Institute on Drug Abuse.
Topics: Adult; Cocaine; Humans; Nitrosamines; Substance-Related Disorders; United States | 1988 |